Mintagesic P

Mintagesic P Uses, Dosage, Side Effects, Food Interaction and all others data.

Mintagesic P, an anthranilic acid derivative, is a prototypical NSAID. It reversibly inhibits the cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) enzymes, thus resulting in reduced synthesis of prostaglandin precursors. It has analgesic and antipyretic properties with minor anti-inflammatory activity.

Mintagesic P, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.

Trade Name Mintagesic P
Generic Mefenamic acid
Mefenamic acid Other Names Acide méfénamique, ácido mefenámico, Acidum mefenamicum, Mefenamic acid, Mefenaminsäure
Type Syrup
Formula C15H15NO2
Weight Average: 241.2851
Monoisotopic: 241.110278729
Protein binding

90%

Groups Approved
Therapeutic Class Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Manufacturer Intas Pharmaceuticals Ltd
Available Country India
Last Updated: September 19, 2023 at 7:00 am
Mintagesic P
Mintagesic P

Uses

Mintagesic P is used in mild to moderate pain including headache, dental pain, postoperative and postpartum pain, dysmenorrhoea, menorrhagia, in musculoskeletal and joint disorders such as osteoarthritis and rheumatoid arthritis; and in children with fever and juvenile idiopathic arthritis.

Mintagesic P is also used to associated treatment for these conditions: Mild pain, Primary Dysmenorrhoea, Gastrointestinal cramps, Moderate Pain

How Mintagesic P works

Mintagesic P binds the prostaglandin synthetase receptors COX-1 and COX-2, inhibiting the action of prostaglandin synthetase. As these receptors have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity, the symptoms of pain are temporarily reduced.

Dosage

Mintagesic P dosage

As with other NSAIDs, the lowest dose should be sought for each patient. Therefore, after observing the response to initial therapy with Mintagesic P, the dose and frequency should be adjusted to suit an individual patient's needs.Administration is by the oral route, preferably with food.

  • Adult: A 500 mg dose should be given to adults up to three times (1.5 g total) per day.
  • Infants over 6 months: 25 mg/kg of body weight daily in divided doses for not longer than 7 days.

Side Effects

In patients taking Mintagesic P or other NSAIDs, the most frequently reported adverse experiences include : abdominal pain, constipation, diarrhoea, dyspepsia, flatulence, gross bleeding/perforation, heartburn, nausea, GI ulcers, vomiting, abnormal renal function, anaemia, dizziness, oedema, elevated liver enzymes, headache, increased bleeding time, pruritus, rash and tinnitus.

Toxicity

Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.

Precaution

NSAIDs should be prescribed with extreme caution in those with a prior history of ulcer disease or gastrointestinal bleeding. To minimise the potential risk for an adverse GI event, the lowest effective dose should be used for the shortest possible duration. In cases with pre-existing advanced kidney disease, treatment with Mintagesic P is not recommended.

Interaction

Concomitant use with CYP2C9 isoenzyme inhibitors may alter safety and efficacy of mefenamic acid. May enhance methotrexate toxicity. Reduced BP response to ACE inhibitors or angiotensin II receptor antagonists. Increased risk of serious GI events with aspirin. May reduce the natriuretic effects of furosemide or thiazide diuretics. Reduced renal lithium clearance and elevated plasma lithium levels. May enhance anticoagulant effect of warfarin.

Food Interaction

  • Avoid alcohol.
  • Take with food.

Volume of Distribution

  • 1.06 L/kg [Normal Healthy Adults (18-45 yr)]

Elimination Route

Mintagesic P is rapidly absorbed after oral administration.

Half Life

2 hours

Clearance

  • Oral cl=21.23 L/hr [Healthy adults (18-45 yrs)]

Elimination Route

The fecal route of elimination accounts for up to 20% of the dose, mainly in the form of unconjugated 3-carboxymefenamic acid.3 The elimination half-life of mefenamic acid is approximately two hours. Mintagesic P, its metabolites and conjugates are primarily excreted by the kidneys. Both renal and hepatic excretion are significant pathways of elimination.

Pregnancy & Breastfeeding use

Pregnancy: In late pregnancy, as with other NSAIDs, Mintagesic P should be avoided because it may cause premature closure of the ductus arteriosus. In general there are no adequate and well controlled studies in pregnant women. Mintagesic P should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus. Rated as Pregnancy Category C.

Lactation: Trace amounts of Mintagesic P may be present in breast milk. Taking into account the importance of the drug to the mother , decision should be made whether to discontinue nursing or to discontinue the drug.

Contraindication

Mintagesic P is contraindicated in patients with known hypersensitivity to Me Mintagesic P acid. Mintagesic P should not be given to patients who have experienced asthma, urticaria, or allergic type reactions after taking aspirin or other NSAIDs. Rarely fatal, anaphylactic like reactions to NSAIDs have been reported in such patients. Mintagesic P is contraindicated in patients with active ulceration or chronic inflammation of upper gastrointestinal tract and should not be used in patients with preexisting renal disease.

Acute Overdose

Symptoms: Headache, nausea, vomiting, epigastric pain, GI bleeding. Rarely, diarrhoea, disorientation, excitation, coma, drowsiness, tinnitus, fainting, and occasionally convulsions.

Management: Symptomatic and supportive treatment. In acute overdosage, empty the stomach immediately by inducing emesis or by gastric lavage followed by admin of activated charcoal.

Storage Condition

Store between 20-25° C.

Innovators Monograph

You find simplified version here Mintagesic P

Mintagesic P contains Mefenamic acid see full prescribing information from innovator Mintagesic P Monograph, Mintagesic P MSDS, Mintagesic P FDA label

FAQ

What is Mintagesic P used for?

Mintagesic P is used short-term to treat mild to moderate pain in adults and children who are at least 14 years old.

How safe is Mintagesic P?

Mintagesic P may increase your risk of heart problems, including heart attack, stroke, heart failure, or blood clot. These conditions can be fatal. Your risk may increase if you already have heart disease or have taken the medication for a long period of time or at high doses.

How does Mintagesic P work?

Mintagesic P works by stopping the body's production of a substance that causes pain, fever, and inflammation.

What are the common side effects of Mintagesic P?

Common side effects of Mintagesic P are include:

  • diarrhea.
  • constipation.
  • gas or bloating.
  • headache.
  • dizziness.
  • nervousness.
  • ringing in the ears

Is Mintagesic P safe during pregnancy?

Use of Mintagesic P during pregnancy is not advised unless prescribed by a doctor, especially if you are 30 or more weeks pregnant.

Is Mintagesic P safe during breastfeeding?

Mintagesic P passes into breast milk and is not recommended for use while breastfeeding.

Can I drink alcohol with Mintagesic P?

Do not drink alcohol while taking Mintagesic P. Alcohol can increase your risk of stomach bleeding caused by Mintagesic P. Call your doctor at once if you have symptoms of bleeding in your stomach or intestines.

Can I drive after taking Mintagesic P?

Mintagesic P Tablets may cause drowsiness, fatigue, dizziness or may affect your vision. If you experience any of these symptoms, you should not drive or operate machinery, or perform any tasks which may require you to be alert.

When should be taken of Mintagesic P?

Mintagesic P is usually taken with food every 6 hours as needed for up to 1 week.

Is it safe to take Mintagesic P?

Mintagesic P should not be used for longer than 7 days.

How many times can I take Mintagesic P?

Mintagesic P take 250 mg every six hours as needed. You shouldn't take Mintagesic P for longer than three days.

How long does Mintagesic P take to work?

If you wait until the symptoms have worsened,Mintagesic P may not work as well. If you are using Mintagesic P for painful periods, take your first dose as soon as your period starts or pain begins. Usually, you will only need to take it for the first 2 to 3 days of your period.

How long does it take for Mintagesic P to kick in?

Mintagesic P takes between 2 - 4 hours to kick in and start easing your period pain. Each 500mg dose of Mintagesic P kills pain for up to 8 hours, so you may need to take it two or three times a day for all-day relief.

Can I take Mintagesic P for a long time?

Mintagesic P should not be used for longer than 7 days. Follow your doctor's dosing instructions very carefully. If you use Mintagesic P long-term, you may need frequent medical tests.Mintagesic P can cause unusual results with certain medical tests.

Who should not take Mintagesic P?

Mintagesic P can increase your risk of fatal heart attack or stroke. Do not use Mintagesic P just before or after heart bypass surgery .Mintagesic P may also cause stomach or intestinal bleeding, which can be fatal.

What happens if I miss a dose on Mintagesic P?

Take Mintagesic P as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What happen if I take too much Mintagesic P?

If you take too much If you take too much Mintagesic P, you may experience: drowsiness, nausea,vomiting.

When can I stop taking Mintagesic P?

If you experience any of the following symptoms, stop taking Mintagesic P and call your doctor: stomach pain, heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, or black and tarry stools.

Can Mintagesic P affects my heart ?

Mintagesic P can increase your risk of fatal heart attack or stroke, especially if you use it long term or take high doses, or if you have heart disease.

*** Taking medicines without doctor's advice can cause long-term problems.
Share